CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Zhejiang Teruisi Pharmaceutical Inc.

For profitWebsite ↗

Also known as: Zhejiang Teruisi Pharmaceutical Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Sep 30, 2025

Defunct as of Nov 3, 2019

Timeline

2010s

Jun 1, 2010
Zhejiang Teruisi Pharmaceutical Inc.— Founded
Nov 3, 2019
Zhejiang Teruisi Pharmaceutical Inc.— Defunct

Drugs by trial phase (12 distinct, 6 trials)

Phase 3 (7 own, 0 via acquisition)

Phase 2 (4 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

rc48-adc

Indications

Studied for

Carcinoma, Non-Small-Cell Lung

Recent trials (6)

NCT06886139Lead sponsorPhase 2Sep 30, 2025
NCT07035379Lead sponsorPhase 1/Phase 2Sep 1, 2025
NCT05378867Lead sponsorPhase 3Aug 1, 2022
NCT05395533Lead sponsorPhase 1Sep 8, 2020
NCT04416035Lead sponsorPhase 3Jul 10, 2020
NCT03882424Lead sponsorPhase 1Jun 12, 2018

Details

Founded: Zhejiang, CN Jun 1, 2010
Last known activity: Sep 30, 2025